Today marks the introduction of a new skincare product known as Vol.u.lift, which incorporates the GLP-1 4D Skin Rebound Complex. Developed by plastic surgeon Dr. Marc Ronert, this product aims to address the four visible effects of rapid weight loss induced by GLP-1 therapies on facial skin, specifically deflation, deep wrinkles, dehydration, and density loss.
Vol.u.lift is characterized as an all-in-one treatment and is the first of its kind in this category. The formulation is based on extensive research into the skin’s response to rapid weight loss associated with GLP-1 use, which is known to accelerate the visible signs of aging. This product is designed for both corrective and preventive applications, employing a multi-faceted approach to meet the changing needs of consumers.
Clinical trials conducted in partnership with dermatologist Raja Sivamani have shown visible results within two weeks for participants using Vol.u.lift. The product is manufactured by Image Skincare, a prominent brand in the professional skincare market, and features the proprietary XOSM Technology, which is a next-generation, patent-pending innovation. Additionally, it contains L-Ornithine amino acid, which external clinical studies suggest may enhance fatty tissue volume, diminish the appearance of structural aging, and improve skin plumpness.